Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation
- Conditions
- Tobacco Use DisorderSmoking
- Interventions
- Other: Pharmacist-delivered group program for smoking cessationOther: Brief standard care session for smoking cessation delivered over the telephone
- Registration Number
- NCT00670904
- Lead Sponsor
- University of Montana
- Brief Summary
This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR or nicotine patch at no cost. At 6 months after the established quit date, self-reported cessation was biochemically verified using tests for urinary cotinine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
- Smoked one or more cigarettes daily for 7 days
- Somewhat ready to quit in the next 2 weeks (4 or more on a 10- point scale)
- Willing and capable of attending three scheduled sessions at the clinic
- Interested in participating in the study
- Planned to leave the area in the next 6 months
- Used pharmacotherapy for smoking cessation in the last 30 days
- Used other forms of tobacco in the last 30 days
- Schizophrenia
- Prior participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Pharmacist-delivered group program for smoking cessation Pharmacist-delivered group program for smoking cession. 2 Brief standard care session for smoking cessation delivered over the telephone Brief standard care session for tobacco smoking cessation delivered over the telephone.
- Primary Outcome Measures
Name Time Method The primary outcome variable for the study was biochemically verified 7-day point prevalence smoking cessation at 6 months, defined as having smoked no cigarettes - not even a puff - for the previous 7 days. 6 months
- Secondary Outcome Measures
Name Time Method Secondary outcomes included 30-day point prevalence abstinence and prolonged abstinence (>6 months). 6 months
Trial Locations
- Locations (1)
Missoula VA Clinic
🇺🇸Missoula, Montana, United States